ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: In the German CML IV experience, achieving BCR::ABL1 (IS) transcripts < 10% at 3 months was associated with a 5-year OS rate of 94%, compared with 90% if levels were >10% [10].